Immunoreactivity of a G protein-coupled l-DOPA receptor GPR143, in Lewy bodies

•We generated an antibody raised against human GPR143, a l-DOPA receptor.•Immunoreactive signals of GPR143 are localized in Lewy bodies.•GPR143 is colocalized with phosphorylated α-synuclein at Ser129. l-3,4-Dihydroxyphenylalanine (l-DOPA) has been believed to be an inert amino acid precursor of dop...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience research Vol. 148; pp. 49 - 53
Main Authors Goshima, Yoshio, Watanabe, Shuya, Seki, Erika, Koga, Motokazu, Masukawa, Daiki, Nakamura, Fumio, Komori, Takashi, Arai, Nobutaka
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.11.2019
Subjects
Online AccessGet full text
ISSN0168-0102
1872-8111
1872-8111
DOI10.1016/j.neures.2018.12.004

Cover

Loading…
More Information
Summary:•We generated an antibody raised against human GPR143, a l-DOPA receptor.•Immunoreactive signals of GPR143 are localized in Lewy bodies.•GPR143 is colocalized with phosphorylated α-synuclein at Ser129. l-3,4-Dihydroxyphenylalanine (l-DOPA) has been believed to be an inert amino acid precursor of dopamine, and is the most effective therapeutic agent in Parkinson’s disease (PD). We proposed l-DOPA as a neurotransmitter in the central nervous system. Recently, the ocular albinism 1 gene product, OA1/GPR143 (GPR143), was identified as a receptor for l-DOPA. In this study, we examined by generating anti-human GPR143 antibody, the localization of GPR143-immunoreactive signals in the brains from control and PD subjects. GPR143-immunoreactive signals were detected throughout the entire midbrain including substantia nigra pars compacta. In the PD brains, we found that GPR143-immunoreactive signals were detected in Lewy bodies and were colocalized with immunoreactive signals with anti-human Ser129 phosphorylated α-synuclein antibody. Although the significance of its occurrence in the inclusion bodies is unknown, our finding suggests possible implications of GPR143 in PD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-0102
1872-8111
1872-8111
DOI:10.1016/j.neures.2018.12.004